On June 12, 2025, ImmuCell Corporation held its Annual Meeting where directors were elected, and resolutions on executive compensation and the stock incentive plan were discussed, with the latter two not approved. 95.93% of shares voted in favor of ratifying Wipfli LLP as auditors for the year ending December 31, 2025.